— Know what they know.
Not Investment Advice

SCYX NASDAQ

SCYNEXIS, Inc.
1W: +16.6% 1M: -1.9% 3M: +8.2% YTD: +701.9% 1Y: +533.4% 3Y: +142.7% 5Y: -8.2%
$5.12
-0.25 (-4.66%)
 
Weekly Expected Move ±11.7%
$4 $5 $5 $6 $6
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 53 · $32.2M mcap · 6M float · 3.97% daily turnover · Short 54% of daily vol

Balance Sheet Trends

Total Assets
$59M -34.9% ▼
5Y CAGR: -10.5%
Total Liabilities
$10M -72.9% ▼
5Y CAGR: -34.5%
Shareholders Equity
$49M -10.4% ▼
5Y CAGR: +16.8%
Cash & Investments
$21M -64.2% ▼
5Y CAGR: -25.6%
Total Debt
$2M -86.6% ▼
5Y CAGR: -35.7%
Net Debt
-$19M -8814.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$104M$46M$34M$16M$21M
Short-Term Investments$0$28M$40M$43M$0
Cash & ST Investments$104M$74M$74M$59M$21M
Net Receivables$861K$2M$22M$10M$0
Inventory$463K$899K$0$0$0
Other Current Assets$4K$117K$5M$2M$19M
Total Current Assets$109M$79M$102M$72M$40M
Property, Plant & Equip.$3M$3M$2M$2M$2M
Goodwill & Intangibles$1M$408K$0$0$0
Long-Term Investments$218K$163K$24M$16M$16M
Other Non-Current Assets$6M$6M$338K$526K$642K
Total Non-Current Assets$10M$9M$26M$18M$19M
Total Assets$120M$88M$128M$91M$59M
— Liabilities —
Accounts Payable$8M$6M$7M$5M$2M
Short-Term Debt$70K$0$0$14M$483K
Deferred Revenue$0$0$1M$2M$235K
Other Current Liabilities$4M$6M$2M$2M$3M
Total Current Liabilities$14M$18M$16M$24M$6M
Long-Term Debt$40M$45M$12M$0$0
Other Non-Current Liab.$21M$19M$22M$8M$2M
Total Non-Current Liabilities$65M$67M$39M$11M$4M
Total Liabilities$79M$85M$55M$36M$10M
— Equity —
Common Stock$32K$36K$40K$41K$46K
Retained Earnings-$359M-$422M-$355M-$377M-$385M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$41M$3M$73M$55M$49M
Total Liabilities & Equity$120M$88M$128M$91M$59M
— Key Metrics —
Total Debt$44M$49M$15M$16M$2M
Net Debt-$61M$3M-$19M$219K-$19M
Total Investments$218K$28M$64M$59M$16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms